BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2555350)

  • 1. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding.
    Ryan J; Wolitzky B; Heimer E; Lambrose T; Felix A; Tam JP; Huang LH; Nawroth P; Wilner G; Kisiel W
    J Biol Chem; 1989 Dec; 264(34):20283-7. PubMed ID: 2555350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region.
    Astermark J; Stenflo J
    J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXa beta. Effects on the serine protease module and factor X activation.
    Astermark J; Hogg PJ; Stenflo J
    J Biol Chem; 1994 Feb; 269(5):3682-9. PubMed ID: 8106413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
    Astermark J; Sottile J; Mosher DF; Stenflo J
    J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domain.
    Toomey JR; Smith KJ; Roberts HR; Stafford DW
    Biochemistry; 1992 Feb; 31(6):1806-8. PubMed ID: 1310619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for Ca2+ binding to the gamma-carboxyglutamic acid and epidermal growth factor-like regions of factor IX. Studies using intact domains isolated from controlled proteolytic digests of bovine factor IX.
    Astermark J; Björk I; Ohlin AK; Stenflo J
    J Biol Chem; 1991 Feb; 266(4):2430-7. PubMed ID: 1989994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gamma-carboxyglutamic acid and epidermal growth factor-like domains of factor X. Effect of isolated domains on prothrombin activation and endothelial cell binding of factor X.
    Persson E; Valcarce C; Stenflo J
    J Biol Chem; 1991 Feb; 266(4):2453-8. PubMed ID: 1989997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IX on factor X activation. Studies using proteolytic fragments of bovine factor IX.
    Astermark J; Hogg PJ; Björk I; Stenflo J
    J Biol Chem; 1992 Feb; 267(5):3249-56. PubMed ID: 1737781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein structural requirements and properties of membrane binding by gamma-carboxyglutamic acid-containing plasma proteins and peptides.
    Schwalbe RA; Ryan J; Stern DM; Kisiel W; Dahlbäck B; Nelsestuen GL
    J Biol Chem; 1989 Dec; 264(34):20288-96. PubMed ID: 2584218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of human factor IX to endothelial cells is mediated by residues 3-11.
    Cheung WF; Hamaguchi N; Smith KJ; Stafford DW
    J Biol Chem; 1992 Oct; 267(29):20529-31. PubMed ID: 1400370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
    Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
    Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.
    McCord DM; Monroe DM; Smith KJ; Roberts HR
    J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The entire gamma-carboxyglutamic acid- and helical stack-domains of human coagulation factor IX are required for optimal binding to its endothelial cell receptor.
    Prorok M; Geng JP; Warder SE; Castellino FJ
    Int J Pept Protein Res; 1996 Sep; 48(3):281-5. PubMed ID: 8897096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of specific endothelial cell-binding properties from the procoagulant protein human factor IX into the anticoagulant protein human protein C.
    Geng JP; Christiansen WT; Plow EF; Castellino FJ
    Biochemistry; 1995 Jul; 34(26):8449-57. PubMed ID: 7541242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX.
    Freedman SJ; Blostein MD; Baleja JD; Jacobs M; Furie BC; Furie B
    J Biol Chem; 1996 Jul; 271(27):16227-36. PubMed ID: 8663165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis.
    Jacobs M; Freedman SJ; Furie BC; Furie B
    J Biol Chem; 1994 Oct; 269(41):25494-501. PubMed ID: 7929250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.
    Jones ME; Griffith MJ; Monroe DM; Roberts HR; Lentz BR
    Biochemistry; 1985 Dec; 24(27):8064-9. PubMed ID: 3879187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.